Programme

Friday 14 June

07.00 – 08.00 Registration open
08.00 – 08.10 Welcome
08.10 – 09.25

 

Session 1 – What makes myocardium arrhythmogenic?

Chairs: J. Kautzner and E. Behr

  1. The role of the autonomic nervous system (M. Jongbloed)
  2. Genetics as major player (P. van Tintelen)
  3. Lessons learned from CMR (C. de Chillou)
  4. AI will clarify (N. Trayanova)
  5. Q&A panel
09.25 – 10.35 Session 2 – Leadless, wearable, extravascular, transvenous: Defibrillator update

Chairs: K. Vernooy and N. Dagres

  1. Dual-chamber leadless pacing and leadless pacemaker-defibrillator: expectations and achievements (S. Richter)
  2. Wearable cardioverter defibrillator – who, when and how long to bridge? (C. de Chillou)
  3. Debate 1: Extravascular ICD will change the future of ICD (pro L. Boersma, con J. Kautzner)
  4. Q&A panel
10.35 – 11.00 Coffee break
11.00 – 12.15 Session 3 – CSP or CRT: update 2024  

Chairs: L. Stevenson and S. Richter

  1. The human conduction system – what you need to know (including anatomical demonstrations) (M. Didenko)
  2. Optimisation of CSP in heart failure – can we do better? (K. Vernooy)
  3. Debate 2: CSP should replace CRT (pro Z. Whinnett, con J. Cosedis Nielsen)
  4. Q&A panel
12.15 – 13.15 Lunch break
13.15 – 14.30 Session 4 – Channelopathies: State of the art diagnostic and treatment

Chairs: M. Hocini and P. van Tintelen

  1. Provocation tests and PES – when and how to use in PED (E. Behr)
  2. Brugada syndrome – drugs or ablation or wait, and see? (A. Sarkozy)
  3. LQT – from gene specific drug treatment to interventional treatment (N. Blom)
  4. CPVT – acute and long-term management (C. van der Werf)
  5. Q&A panel
14.30 – 15.15 Session 5 – Young EP arena I (3 case presentations and panel discussion: 45 min)

Chairs: J. Cosedis Nielsen, S. Piers, S. Richter, Z Whinnett

15.15 – 15.40 Coffee break
15.40 – 17.00 Session 6 – VT management: update on trials and registries

Chairs: P. Jais and J. Cosedis Nielsen

  1. PROFID: a game changer? (N. Dagres)
  2. PROTECT – TOF: a multicentre registry (K. Zeppenfeld)
  3. Does early VT ablation improve outcome? (P. della Bella)
  4. Survival of ICD patients in 2024 – data from a Czech nationwide registry (J. Kautzner)
  5. Impact of optimized heart failure treatment on VA – what is the evidence? (L. Stevenson)
  6. Q&A panel
17.00 Reception

Saturday 15 June

07.30 – 08.00 Registration open
08.00 – 09.15 Session 7 – PVCs: evaluation, ablation and outcome

Chairs: P. della Bella and M. Valderrábano

  1. Patients with PVCs – what diagnostics do we need, what can we spare? (D. Muser)
  2. What do we need to have in the box if we address patients with a low PVC burden? (T. Deneke)
  3. What is your mapping and ablation strategy for PVCs from the outflow tracts? (F. Marchlinski)
    Simultaneous anatomical demonstrations on human specimen (M. Didenko)
  4. What is your mapping and ablation strategy for PVC from unique sites (e.g. para-hisian, MCV, posterior-septal process, mitral or tricuspid valve annuli, papillary muscle) (F. Garcia)
    Simultaneous anatomical demonstrations on human specimen (M. Didenko)
  5. Q&A panel
09.15 – 10.15 Session 8 – Live in the Box

Chairs: P. Peichl and P. Jais

  1. Coronary venous mapping step by step (F. Garcia)
  2. Venous alcohol ablation in structural heart disease (M. Valderrábano)
  3. Needle mapping and ablation (W. Stevenson)
  4. Q&A panel
10.15 – 10.45 Coffee break
10.45 – 12.00 Session 9 – Approaches to VT substrates – hype or reality in 2024?

Chairs: J. Kautzner and K. Zeppenfeld

  1. Imaging guided ablation (P. Jais)
  2. PFA and large footprint catheters (RF/PFA) (T. Deneke)
  3. Stereotactic radiotherapy (P. Peichl)
  4. Epicardial approach: homogeneous indications? (C. Bisceglia)
  5. Q&A panel
12.00 – 13.00 Session 10 – Young EP arena II (4 case presentations and panel discussion: 60 min)

Chairs: W. Stevenson, K. Zeppenfeld, F. Marchlinski, A. Wijnmaalen

13.00 – 14.00 Lunch break
14.00 – 15.30 Session 11 – Mapping and ablation: What do we have and what is needed? Session I

Chairs: C. de Chillou and P. della Bella

  1. You need to know the basics: electrogram recordings and filter settings (W. Stevenson)
  2. Bipolar and unipolar voltage mapping – value, field of view, limitations and learning to use the slider bar (K. Zeppenfeld)
  3. Multi electrode catheter mapping: grid, multiple splines, linear electrodes, bipolar or omnipolar – what to choose and when? (F. Sacher)
  4. Pearls and pitfalls of pace-mapping (F. Bogun)
  5. How to perform and interpret entrainment mapping (A. Sultan)
  6. Q&A panel
15.30 – 16.45 Session 12 – Mapping and ablation: What do we have and what is needed? Session II

Chairs: T. Deneke and F. Marchlinski

  1. Functional substrate mapping – ILAM, EDP and DEEP (M. de Riva)
  2. Intramural substrate in NICM – recognition and ablation options (F. Bogun)
  3. VF – VPD trigger and substrate mapping – which patients, where to find, best provocation techniques and endpoints? (M. Hocini)
  4. Complications of VT ablation – how to recognize, how to avoid? (P. Della Bella)
  5. Q&A panel
16.45 Adjourn